fda journavx - Search News

FDA approves non-opioid pain medication

U.S. News & World Report · 1d

What to Know About Journavx, the Non-Opioid Pain Medication Just Approved by the FDA

The drug, suzetrigine, will be sold under the brand name Journavx and is the first new class of pain medicine approved in more than 20 years.

The Washington Post · 1d

FDA approves new, non-opioid painkiller Journavx

The drug, shown to be almost as effective as opioids for short-term pain, is the first fundamentally new kind of painkiller to win FDA approval in more than 20 years.

Hosted on MSN · 1d

FDA approves new pain medication as an alternative to opioids: What to know about Journavx

The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under the brand name Journavx.

1don MSN

What is Non-Opioid Pain Medication? Journavx Approved by FDA

The new non-opioid drug has been approved for the treatment of severe pain, such as that following surgery or an injury.

1d

Buy Rating for Vertex Pharmaceuticals: FDA Approval of Journavx Boosts Market Potential and Stock Price Target

Analyst Andrew Fein of H.C. Wainwright maintained a Buy rating on Vertex Pharmaceuticals (VRTX – Research Report), boosting the price target to ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results